Skip to content

DR. NICKMANS SILVIE

Active
Private limited companyfounded 2015active for 11 yearsKloosterlaan 48, 3500 Hasselt, BelgiumKBO/BCE: BE 0633.842.342
Summary

DR. NICKMANS SILVIE has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600 and a net result of €359,629. Equity has been shrinking by about 25% per year since 2018. If that trend continues, it turns negative around financial year 2026. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 14-07-2015 Normal situation
Activity
“De uitoefening van de geneeskunde met beroepsbekwaamheid klinische biologie, door de arts-aandeelhouders met inachtname…” (deed in Dutch)From the articles, 13 activitiesNo NACE code in the KBO yet
Establishment unit
2.243.697.892 3500 Hasselt, since 14-07-2015
Financial year end
31 December
Peppol
Reachable since 20-06-2025

Board and ownership

Board

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€492,979
▲ 77.9%
Turnover
≈ €980,000
estimated
Profit
€359,629
▲ 78.7%
Equity
€18,600
=
Total assets
€451,041
▲ 33.8%
Score breakdownraises riskEquity €18,600 (4.1% of total assets)lowers riskSize: total assets €451,041No main activity registeredLiquidity: current ratio 0.88, cash €363,781Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 29-2
equity 4.1% of total assets
Liquidity 50=
short-term debt 95.8% · cash 80.7%
Profitability 100=
return on assets 79.7%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.2%▲ +0.1 percentage points vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.4%▲ +0.1 percentage points vs 08-2025highest value 10-2025: 0.1%▼ -0.3 percentage points vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026lowest value 11-2026: 0.1%● unchanged vs 10-2026lowest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.88 (0.8 in 2024), below 1. Short-term debt is 95.8% and cash 80.7% of total assets. 95.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 19% of them on solvency, 35% on liquidity, 90% on profitability and 47% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €451,041
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · No main activity registered
KBO
raises risk · Equity €18,600 (4.1% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.88, cash €363,781
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-05-2026, 88 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
88 days early
2024
29 days late
2023
21 days late
2022
4 days early
2021
6 days early
2020
5 days late
2019
24 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 3 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (4 of the last 5 accounts filed within 33 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Result rose in 2025from €201,230 to €359,629 ▲ 78.7% View
  • Positive: 8 profitable years in a rowprofit 2025: €359,629 8 years View

Recent changes

  1. · Gazette deed Resignation: NICKMANS Silvie Antonie Joseph (statutory director)Reappointment: NICKMANS Silvie Antonie Joseph (statutory director) · Appointment: NICKMANS Silvie Antonie Joseph (statutory director)
  2. · Gazette deed Incorporation
All 13 events

Key facts about DR. NICKMANS SILVIE

What is the company number of DR. NICKMANS SILVIE?
The company number of DR. NICKMANS SILVIE is 0633.842.342. The VAT number is the same number with BE in front: BE 0633.842.342.
Where is DR. NICKMANS SILVIE based?
The registered office is at Kloosterlaan 48, 3500 Hasselt.Company details
What is the legal form of DR. NICKMANS SILVIE?
The legal form of DR. NICKMANS SILVIE is Private limited company (BV).
When was DR. NICKMANS SILVIE founded?
DR. NICKMANS SILVIE was founded on 14-07-2015.
Is DR. NICKMANS SILVIE still active?
Yes, DR. NICKMANS SILVIE is an active enterprise in the KBO register.
How many employees does DR. NICKMANS SILVIE have?
DR. NICKMANS SILVIE had an average of 0.6 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
What is the turnover of DR. NICKMANS SILVIE?
The turnover in financial year 2025 is ≈ €980,000. This figure is estimated from the gross margin of €492,979 and 883 comparable companies of the same size. It probably lies between €690,000 and €1.4m. It is a rough estimate.
Is DR. NICKMANS SILVIE profitable?
In financial year 2025, DR. NICKMANS SILVIE made a profit of €359,629.
Where can I find the annual accounts of DR. NICKMANS SILVIE?
DR. NICKMANS SILVIE filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. NICKMANS SILVIE due?
DR. NICKMANS SILVIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.